chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd she got fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (2nd she got fever) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 201B21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LAMOTRIGINE (LAMICTAL), OXCARBAZEPINE, GABAPENTIN, QUETIAPINE, HYDROCHLOROTHIAZIDE, OMEPRAZOLE, NALTREXONE, PROBIOTICS NOS, LYSINE, VITAMIN D3, MELATONIN, NATTOKINASE, RESVERATROL, MONOLAURIN [GLYCERINE MONOLAURATE], FISH OIL, VITAMIN C [ASCORBIC ACID] and LEVETIRACETAM (LEVRA) for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (2nd she got fever). At the time of the report, PYREXIA (2nd she got fever) outcome was unknown.            Concomitant medications also include sertiamen and IGG infusions weekly.  No treatment medication were reported.   This case was linked to MOD-2021-296523, MOD-2021-296516 (Patient Link).
Patient stating that his arm was swollen and burning sensation and he was in bed for five days after the shots due to pain and discomfort.
FEEL SICK; VOMITING; NAUSEA; FEVER; This spontaneous report received from a patient concerned a 76 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: asthma, penicillin allergy, seasonal allergy, green pepper, and mineral allergy. The patient previously received covid-19 vaccine ad26. cov2. s (dose number in series 1) (suspension for injection, route of admin not reported, and batch number: 207A21A and expiry: unknown) dose was not reported, 1 total, administered on 07-JUL-2021 to left arm for prophylactic vaccination. No adverse events were reported (dose number series1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1822809 and expiry: unknown) dose was not reported, 1 total, administered on 03-JAN-2022 to left arm for prophylactic vaccination. Concomitant medications included diphenhydramine hydrochloride (Benadryl) for allergies.  On 08-JAN-2022, the patient had reaction after her booster dose including nausea, vomiting which was for an hour. The patient had fever and also felt sick. On the day of reporting (13-JAN-2022), she did not had vomiting. She saw the health care professional (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting on 13-JAN-2022, and the outcome of nausea, fever and feel sick was not reported. This report was non-serious.
Returned 35 min post injection c/o feeling light headed, tingling in face, and neck. observed patent to have generalized redness of face and neck area. within 3 min small red blotches inner forearms, itching in scalp and neck. Pt c/o swelling in upper lip which was present. 911 was called  & at  4:33 pm Epinephrine 0.3ml 1:1000 given left lateral thigh area . 120/76 P- 110, R-20 Pulse oxy  96 %. 4:37 EMS arrived and transported patient to Er.
swelling head to toe; lymph nodes and everything were swollen; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A 60 year-old male patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "leukemia" (unspecified if ongoing), notes:  He was a 60 year old male with the underlying medical condition of leukemia, which was in remission. The patient's concomitant medications were not reported. The following information was reported: SWELLING (hospitalization) with onset 2021, outcome "unknown", described as "swelling head to toe"; LYMPHADENOPATHY (hospitalization) with onset 2021, outcome "unknown", described as "lymph nodes and everything were swollen". The patient was hospitalized for swelling, lymphadenopathy (start date: 2021, discharge date: 2021).  Clinical course: Caller stated she wanted to stay anonymous but she knew a person who had the first dose of the Pfizer Covid vaccine and soon after had swelling head to toe. Caller stated that his lymph nodes and everything were swollen. Caller said he was a 60 year old male with the underlying medical condition of leukemia, which was in remission.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported heightened sensitivity on her arms, scalp, torso, and back. Simple activities like putting on clothes and brushing her hair caused significant discomfort.  Patient also said sensitivity began going away the beginning of the new year (2023).
Pt's left arm got swollen and painful. One week later swelling is gone but there is a dark mark on arm, just above elbow, still painful.
A week after the vaccine, I developed "covid arm" (a red, itchy circular patch at the injection site). Then almost week after that, I developed swelling on my lips, a raised, red, itchy rash around my lips, on my chip/neck, and on my right eyelid. The eyelid also swelled slightly. I visited my doctor and was given a steroid injection and a prescription for prednisone. I was also instructed to take Benadryl at night and pepsid and claritin during the days to counteract the reaction.  Of note: I received a Botox injection in my forehead on Feb. 22nd, 2021.
My skin is hot and Inchy torso and up worst is my arms both injection and none injection chest and upper back feels like a sunburn light dull constant pain warm to the touch skin but feels just like I got sunburned
Systemic: Dizziness / Lightheadness-Mild, Systemic: Hypotension-Mild
Dizziness about 15 minutes after. Hard time swallowing 20 minutes after.  Both cleared up in 24 hours.  5 days after vaccine random dizziness occurs and blurry vision started.
pain and swelling at site of injection; pain and swelling at site of injection; body pain; headache; stuffy nose; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Oct2022 as dose 4 (booster), single (Lot number: GJ5342) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 3 (Booster), single, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 2; Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 1; Manufacturer unknown), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 28Oct2022, outcome "not recovered", described as "body pain"; HEADACHE (non-serious) with onset 28Oct2022, outcome "not recovered"; VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 28Oct2022, outcome "not recovered" and all described as "pain and swelling at site of injection"; NASAL CONGESTION (non-serious) with onset 28Oct2022, outcome "not recovered", described as "stuffy nose". Therapeutic measures were not taken as a result of vaccination site swelling, vaccination site pain, pain, headache, nasal congestion.  Additional information: She received Pfizer Bivalent Booster on 28Oct2022 in the evening. After few hours of vaccination, she had pain and swelling at site of injection. Later at night she started having body pain, headache and stuffy nose. All events are ongoing. Patient did not had Covid prior to vaccination. Patient was not tested covid post vaccination. Patient had no known allergies.
Defecating bright red blood per rectum and mucus in stool. Happened also with first dose at age 2 months but was assured by pediatrician it wasn't due to vaccine and instead was due to mother's diet. At 2 months patient passed 3 stools with bright red blood 24 hours after 1st dose of rotarix. Mother has eliminated all dairy, soy, and other allergens. 24 hours after receiving second dose of ROTARIX, passing bright red blood again.
Breakthrough case admission after three vaccines  Pfizer 1/22/21 Lot# El3248;  Pfizer 2/12/21 Lot# Em9810;  Pfizer 12/4/21 Lot# FJ8762
Information was received from a physician referring a 11 year old female patient. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 09-APR-2017 the patient was vaccinated with GARDASIL 9 dose 1, intramuscularly (dose, frequency, lot number and expiration date were not reported) as prevention of human papilloma virus. Concomitant medications included other unspecified vaccines at the same time of the administration of GARDASIL 9. Also in April 2017, after the vaccine was administered the patient experienced fainting. No treatment was administered. At the time of reporting, the patient was recovered from the event of fainting. The causal relationship between the event and therapy with GARDASIL 9 was not reported. Additional information is not expected because there was no consent to contact physician.
Foot pain; joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2021US105763_OS.  A 76-year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Foot pain"; ARTHRALGIA (non-serious), outcome "unknown", described as "joint pain".  Follow-up attempts are completed. No further information is expected.
Woke up feeling extremely nauseous.  Threw up three times and felt very weak.  Had a fever, chills and my legs felt like jello.  Woke up at 7:00 am, and the only symptom left is a fatigue.
It's been over a week and my entire right arm is still swollen and red.  Very sore.  For two days after the injection I was completely wiped-out.  I have not gone back to the doctor because I realize there is not much he can do.  I have kidney disease and can not take drugs that would normally bring down the swelling.  I've had flu shots for many years and have never had any problems.  I guess is you have changed some of the ingredients in the formulation.   I will never have another flu shot.
soreness in arm of injection; headache; nausea; This is a spontaneous report from a contactable consumer. This 32-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 14May2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. On an unknown date, the patient experienced soreness in arm of injection and a headache. The patient stated last week, and past 2 days complains of nausea and was wondering if she was still would be having this. Outcome of the events was unknown.
Received the FLULAVAL flu shot. Experiencing severe muscle pain, which is worsening my current injury, nausea, vomiting, headaches, and irritability.
Information has been received from a physician and a medical assistant concerning a 17 month old Hispanic female who on 11/05/2001 at 10:30 am was vaccinated with the first dose of varicella virus vaccine live in the right anterior thigh. Concomitant vaccinations that same day and time included the first dose of MMRII. other concomitant therapy included acetaminophen (Tylenol). There was no illness at the time of vaccination. On 11/13/01, (also reported as nine days post-vaccination), the pt was seen with a fever of approximately 102.9 (also reported as a temp of 103.2) 2 loose bowel movements and rash on her face, scalp and torso. The pt received treatment with acetaminophen (Tylenol). It was noted that the pt did not require prescripotion drug treatment. The pt was seen in two days later and the rash was noted to be resolving. There were no vesicular lesions seen and the fever was down. It was noted that the pt recovered. The pt was reported to be a previously healthy female with no known immune deficiencies. No further information is available.
It was very similar to flu; very low energy. I didnt have any vomiting or diarrhea but it was very low energy and very hard; could not concentrate; and very tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77 year-old patient received bnt162b2 (BNT162B2), intramuscular, administration date 03Nov2021 11:00 (Lot number: FDO809) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Heart Attack", start date: 17Dec2017 (unspecified if ongoing); "Asthma" (unspecified if ongoing), notes: Childhood. Concomitant medication(s) included: FLU taken for immunisation; ATORVASTATIN taken for myocardial infarction, start date: 2017 (ongoing); ASPIRIN [ACETYLSALICYLIC ACID] taken for myocardial infarction (ongoing); MONTELUCAST taken for asthma. Vaccination history included: Bnt162b2 (1st dose, Consumer further stated, "Anyway I just wanted to report that I had very strong reaction and I didnt have any reaction to the first two Pfizer shots.", Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot no# EL9261), administration date: 10Feb2021, for Covid-19 Immunization; Bnt162b2 (2nd dose, Consumer further stated, "Anyway I just wanted to report that I had very strong reaction and I didnt have any reaction to the first two Pfizer shots.", Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot no# EN6205), administration date: 10Mar2021, for Covid-19 Immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "It was very similar to flu"; ASTHENIA (non-serious), outcome "unknown", described as "very low energy. I didnt have any vomiting or diarrhea but it was very low energy and very hard"; DISTURBANCE IN ATTENTION (non-serious), outcome "unknown", described as "could not concentrate"; FATIGUE (non-serious), outcome "unknown", described as "and very tired". Relevant laboratory tests and procedures are available in the appropriate section. Additional information:: The patient had very strong reaction. It was very similar to flu, very low energy. The patient did not had any vomiting or diarrhea but it was very low energy and very hard, could not concentrate and very tired. So the patient wanted to report that  very strong reaction and didnt had any reaction to the first two Pfizer shots. When reading the papers and reading that the formula used is same. It made me wonder if that is why the patient  had such a strong reaction."  No follow-up attempts are possible. No further information is expected.
Arm was sore, swollen, hot, and red within 2 hours of shot. By today the redness and swelling is 3" to 4" in diameter.  I am fatigued, lethargic.
Patient received vaccine in the morning from another facility. She presented to our office for an infected ingrown toenail. She has had a removal procedure in the past with no contraindications for local anesthesia. On this day, despite several attempts for local infiltration and regional nerve block, she did not go numb for the procedure. This is highly unusual given the amount of anesthetic attempted and after extensive history, the only difference in today's procedure was the patient had received her COVID-19 Vaccine that morning.
Body aches; I had lesion upper part of my buttock a few different times in 2021 /On 8/4/21, I had a lesion develop on the back of my right thigh; I just thought it was a heat rash; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (I had lesion upper part of my buttock a few different times in 2021 /On 8/4/21, I had a lesion develop on the back of my right thigh), MILIARIA (I just thought it was a heat rash) and MYALGIA (Body aches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004m20a and 025j20a) for COVID-19 vaccination.     Patient never been diagnosed with/ tested positive for COVID-19. Patient had no acute illnesses at the time of vaccination and up to one month before.  Concurrent medical conditions included Hypertension since 2018, Anxiety, Cholesterol and Allergy NOS. Concomitant products included MONTELUKAST and LEVOCETIRIZINE DIHYDROCHLORIDE for Allergy NOS, ESCITALOPRAM for Anxiety, ATORVASTATIN CALCIUM for Blood cholesterol abnormal, HYDROCHLOROTHIAZIDE for Hypertension.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 04-Feb-2021, the patient experienced MYALGIA (Body aches). In 2021, the patient experienced SKIN LESION (I had lesion upper part of my buttock a few different times in 2021 /On 8/4/21, I had a lesion develop on the back of my right thigh) and MILIARIA (I just thought it was a heat rash). At the time of the report, SKIN LESION (I had lesion upper part of my buttock a few different times in 2021 /On 8/4/21, I had a lesion develop on the back of my right thigh) and MILIARIA (I just thought it was a heat rash) outcome was unknown and MYALGIA (Body aches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Red blood cell sedimentation rate: elevated to 32 (High) Elevated to 32. On 05-Feb-2021, Rheumatoid factor: elevated to 116 (High) Elevated to 116. On 02-Aug-2021, C-reactive protein: elevated to 0.8 (High) Elevated to 0.8mg/dl.         On Feb-2021, the patient saw her primary care provider with some body aches.  On 05-Feb-2021, she had done lab test. Patient had lesion in upper part of her buttock a few different times in 2021 (unspecified date). Patient just thought it was a heat rash.  On 04-Aug-2021, patient had a lesion developed on the back of her right thigh and this made her take notice more. Patient stated she used over the counter medication (unspecified) for it.  On 13-Aug-2021, it returned again, and patient did a telehealth visit to her primary provider on 27-Aug-2021. Later, she was treated for a bacterial infection, which it was not.   It was reported that, patient had not experienced a similar event in the past.   This case was linked to MOD-2022-554962 (Patient Link).
11/9/03 12 AM left arm swelled up and pain down arm into hand, visible red line on arm and nausea. No temp. ER visit: given Rx for Cephalexin and sent home.
3  days after my 2nd shot I was in the ER with chest pains and trouble breathing. The ER performed an ecg and it was abnormal. Other the next month I had a heart echo, heart mri and heart CT scan. Diagnosed heart failure, myocarditis, dangerous arrhythmia. Have been wearing a life vest for nearly 3 months. Constantly tired.
Information has been received from a registered nurse concerning a 71 year old white retired female who on Mar 07 2005 was vaccinated into the right arm with second dose of pneumococcal 23v polysaccharide vaccine (lot 649981/0704P). On Mar 08 2005, the patient developed swelling and redness. Unspecified medical attention was sought. On Mar 20 2005, the patient recovered. It was reported that the patients last dose of pneumococcal 23v polysaccharide vaccine was 7 years ago. No product quality complaint was involved. It was also reported that an additional patient was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine and developed adverse events WAES0503USA03004). Additional information is not requested.
Immediate symptoms were extreme headache, dizziness and nausea.  Prolonged symptoms currently are headache, dizziness, nausea, tiredness and hypersomnia (sleeping 15 hours per night).
This case was reported by a physician via call center representative and described the occurrence of vasovagal reaction in a 16-year-old female patient who received BEXSERO (batch number 166801A, expiry date 31st May 2018. On 3rd April 2017, the patient received BEXSERO. In April 2017, less than a week after receiving BEXSERO, the patient experienced vasovagal reaction, pallor facial and dizziness. On an unknown date, the outcome of the vasovagal reaction, pallor facial and dizziness were unknown. It was unknown if the reporter considered the vasovagal reaction, pallor facial and dizziness to be related to BEXSERO. Additional details were provided as follows: The patient became pale in face.
Started with fatigue,. chills, fever up to 100.3, muscle aches, severe chest discomfort , heart rate up to 130 .  Is an EMS provider, went to fire house and EKG was normal, just elevated heart rate and BP around 130/80 Fatigue - resulting in lack of eating /appetite
Muscle weakness that lead to passing out multiple times, fever, disoriented, and ended up in the hospital for two days
This is a spontaneous report was received from a contactable consumer. A 76-year-old male patient of weight 77.11 kilograms and height 173 centimetres received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration in arm left on 04Feb2021 09:00 AM as 1st dose, single for covid-19 immunisation. The patient's medical history included blood pressure high and history of headaches this was diagnosed 50 years ago, high cholesterol this was diagnosed 30-40 years ago, stomach problems. Concomitant medications were not reported. On 04Feb2021, the patient had headache. He had his first dose of the vaccine yesterday and wound up with a headache later in the day that lasted all night and gets all the time. He heard that Aspirin should not be taken before or after getting the vaccine. So, he would like to know can he take Excedrin to treat his headache since it was one day after the vaccine dose. He heard that it was a general rule that you should not take aspirin with the vaccines and would like to know if this was true. He said he was supposed to get his second dose of vaccine on February 25th and was thinking that the end date on it for the vaccine was March 13th. Vaccine injection was given at 09:00AM yesterday, then it was not until the evening when his headache started the whole day, and it may have nothing to do with the vaccine since he gets two to three headaches a week. Reason for no lot number was complainant does not have the product with them at the time of call. The outcome of the event was unknown.  Follow-up (19Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected
O  VSS    Pe WNL except for swollen pink upper arm on left with induration of 2x2 cm on subcutaneous injection site.  Warm, A/P local reaction to VZV.